;PMID: 12072425
;source_file_697.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..39] = [t:0..39]
;1)sentence:[e:44..271] = [t:44..271]
;2)section:[e:275..391] = [t:275..391]
;3)section:[e:395..493] = [t:395..493]
;4)sentence:[e:497..698] = [t:497..698]
;5)sentence:[e:699..915] = [t:699..915]
;6)sentence:[e:916..1153] = [t:916..1153]
;7)sentence:[e:1154..1337] = [t:1154..1337]
;8)sentence:[e:1338..1703] = [t:1338..1703]
;9)sentence:[e:1704..1859] = [t:1704..1859]
;10)sentence:[e:1860..2090] = [t:1860..2090]
;11)section:[e:2094..2139] = [t:2094..2139]

;section 0 Span:0..39
;Jpn J Clin Oncol  2002 Apr;32(4):146-51
(SEC
  (FRAG (NNP:[0..3] Jpn) (NNP:[4..5] J) (NNP:[6..10] Clin) (NNP:[11..16] Oncol)
        (CD:[18..22] 2002) (CD:[23..30] Apr;32-LRB-) (CD:[30..32] 4-RRB-)
        (CD:[32..36] :146) (::[36..37] -) (CD:[37..39] 51)))

;sentence 1 Span:44..271
;Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after 
;resection of an intraductal papillary-mucinous carcinoma of the pancreatic
;head:  a case report and comparison of DNA sequence in K-ras gene mutation.
;[44..105]:malignancy:"Invasive ductal adenocarcinoma of the remnant
;pancreatic body"
;[137..200]:malignancy:"intraductal papillary-mucinous carcinoma of the
;pancreatic head"
;[251..256]:gene-rna:"K-ras"
(SENT
  (NP-HLN
    (NP
      
      (NP (JJ:[44..52] Invasive) (JJ:[53..59] ductal)
          (NN:[60..74] adenocarcinoma))
      (PP (IN:[75..77] of)
        (NP (DT:[78..81] the) (NN:[82..89] remnant) (JJ:[90..100] pancreatic)
            (NN:[101..105] body)))
      (NP-TMP
        (NP (CD:[106..107] 9) (NNS:[108..113] years))
        (PP-TMP (IN:[114..119] after)
          (NP
            (NP (NN:[121..130] resection))
            (PP (IN:[131..133] of)
              (NP
                (NP (DT:[134..136] an) (JJ:[137..148] intraductal)
                  (ADJP (JJ:[149..158] papillary) (HYPH:[158..159] -)
                        (JJ:[159..167] mucinous))
                  (NN:[168..177] carcinoma))
                (PP (IN:[178..180] of)
                  (NP (DT:[181..184] the) (JJ:[185..195] pancreatic)
                      (NN:[196..200] head)))))))))
    (::[200..201] :)
    (NP
      (NP (DT:[203..204] a) (NN:[205..209] case) (NN:[210..216] report))
      (DT:[217..220] and)
      (NP
        (NP (NN:[221..231] comparison))
        (PP (IN:[232..234] of)
          (NP
            (NP (NN:[235..238] DNA) (NN:[239..247] sequence))
            (PP (IN:[248..250] in)
              (NP (NN:[251..256] K-ras) (NN:[257..261] gene)
                  (NN:[262..270] mutation)))))))
    (.:[270..271] .)))

;section 2 Span:275..391
;Komori T, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, Nakaizumi A, 
;Uehara H, Tanaka S, Mano Y, Kasugai T.
(SEC
  (FRAG (NNP:[275..281] Komori) (NNP:[282..283] T) (,:[283..284] ,)
        (NNP:[285..293] Ishikawa) (NNP:[294..295] O) (,:[295..296] ,)
        (NNP:[297..305] Ohigashi) (NNP:[306..307] H) (,:[307..308] ,)
        (NNP:[309..315] Yamada) (NNP:[316..317] T) (,:[317..318] ,)
        (NNP:[319..325] Sasaki) (NNP:[326..327] Y) (,:[327..328] ,)
        (NNP:[329..335] Imaoka) (NNP:[336..338] S,) (NNP:[339..348] Nakaizumi)
        (NNP:[349..350] A) (,:[350..351] ,) (NNP:[353..359] Uehara)
        (NNP:[360..361] H) (,:[361..362] ,) (NNP:[363..369] Tanaka)
        (NNP:[370..372] S,) (NNP:[373..377] Mano) (NNP:[378..379] Y)
        (,:[379..380] ,) (NNP:[381..388] Kasugai) (NNP:[389..391] T.)))

;section 3 Span:395..493
;Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular 
;Diseases, Osaka, Japan.
(SEC
  (FRAG (NNP:[395..405] Department) (IN:[406..408] of) (NNP:[409..416] Surgery)
        (,:[416..417] ,) (NNP:[418..423] Osaka) (NNP:[424..431] Medical)
        (NNP:[432..438] Center) (IN:[439..442] for) (NNP:[443..449] Cancer)
        (CC:[450..453] and) (NNP:[454..468] Cardiovascular)
        (NNP:[470..478] Diseases) (,:[478..479] ,) (NNP:[480..485] Osaka)
        (,:[485..486] ,) (NNP:[487..492] Japan) (.:[492..493] .)))

;sentence 4 Span:497..698
;Recently, there have been a few case reports of invasive ductal
;adenocarcinoma  (IDC) developed in the remnant pancreas after partial
;pancreatectomy for  intraductal papillary-mucinous neoplasm (IPMN).
;[545..575]:malignancy:"invasive ductal adenocarcinoma"
;[578..581]:malignancy:"IDC"
;[651..690]:malignancy:"intraductal papillary-mucinous neoplasm"
;[692..696]:malignancy:"IPMN"
(SENT
  (S
    (ADVP-TMP (RB:[497..505] Recently))
    (,:[505..506] ,)
    (NP-SBJ (EX:[507..512] there))
    (VP (VBP:[513..517] have)
      (VP (VBN:[518..522] been)
        (NP-PRD
          (NP (DT:[523..524] a) (JJ:[525..528] few) (NN:[529..533] case)
              (NNS:[534..541] reports))
          (PP (IN:[542..544] of)
            (NP
              (NP
                (NP (JJ:[545..553] invasive) (JJ:[554..560] ductal)
                    (NN:[561..575] adenocarcinoma))
                (NP (-LRB-:[577..578] -LRB-) (NN:[578..581] IDC)
                    (-RRB-:[581..582] -RRB-)))
              (VP (VBN:[583..592] developed)
                (PP-LOC (IN:[593..595] in)
                  (NP (DT:[596..599] the) (NN:[600..607] remnant)
                      (NN:[608..616] pancreas)))
                (PP-TMP (IN:[617..622] after)
                  (NP
                    (NP (JJ:[623..630] partial) (NN:[631..645] pancreatectomy))
                    (PP (IN:[646..649] for)
                      (NP
                        (NP (JJ:[651..662] intraductal)
                          (ADJP (JJ:[663..672] papillary) (HYPH:[672..673] -)
                                (JJ:[673..681] mucinous))
                          (NN:[682..690] neoplasm))
                        (NP (-LRB-:[691..692] -LRB-) (NN:[692..696] IPMN)
                            (-RRB-:[696..697] -RRB-))))))))))))
    (.:[697..698] .)))

;sentence 5 Span:699..915
;It is necessary to clarify their  histogenetic relationships among two
;sporadic tumors and their surrounding duct  epithelium and it would be more
;reliable if genetic analysis is added to the  conventional histology.
;[770..785]:malignancy:"sporadic tumors"
(SENT
  (S
    (S
      (NP-SBJ (PRP:[699..701] It))
      (VP (VBZ:[702..704] is)
        (ADJP-PRD (JJ:[705..714] necessary)
          (S
            (NP-SBJ (-NONE-:[714..714] *))
            (VP (TO:[715..717] to)
              (VP (VB:[718..725] clarify)
                (NP
                  (NP (PRP$:[726..731] their) (JJ:[733..745] histogenetic)
                      (NNS:[746..759] relationships))
                  (PP (IN:[760..765] among)
                    (NP
                      (NP (CD:[766..769] two)
                         (JJ:[770..778] sporadic) (NNS:[779..785] tumors))
                      (CC:[786..789] and)
                      (NP (PRP$:[790..795] their) (VBG:[796..807] surrounding)
                          (NN:[808..812] duct) (NN:[814..824] epithelium)))))))))))
    (CC:[825..828] and)
    (S
      (NP-SBJ (PRP:[829..831] it))
      (VP (MD:[832..837] would)
        (VP (VB:[838..840] be)
          (ADJP-PRD (RBR:[841..845] more) (JJ:[846..854] reliable))
          (SBAR-ADV (IN:[855..857] if)
            (S
              (NP-SBJ-1 (JJ:[858..865] genetic) (NN:[866..874] analysis))
              (VP (VBZ:[875..877] is)
                (VP (VBN:[878..883] added)
                  (NP-1 (-NONE-:[883..883] *))
                  (PP (TO:[884..886] to)
                    (NP (DT:[887..890] the) (JJ:[892..904] conventional)
                        (NN:[905..914] histology))))))))))
    (.:[914..915] .)))

;sentence 6 Span:916..1153
;We report a 76-year-old woman who received  pancreaticoduodenectomy for IPMN
;with a focal in situ carcinoma (IPMC), which  was transitional to the
;surrounding duct epithelium with papillary proliferation  and a wide variety
;of dysplasia.
;[988..1023]:malignancy:"IPMN with a focal in situ carcinoma"
;[1025..1029]:malignancy:"IPMC"
;[1143..1152]:malignancy:"dysplasia"
(SENT
  (S
    (NP-SBJ (PRP:[916..918] We))
    (VP (VBP:[919..925] report)
      (NP
        (NP (DT:[926..927] a)
          (ADJP (CD:[928..930] 76) (HYPH:[930..931] -) (NN:[931..935] year)
                (HYPH:[935..936] -) (JJ:[936..939] old))
          (NN:[940..945] woman))
        (SBAR
          (WHNP-2 (WP:[946..949] who))
          (S
            (NP-SBJ-2 (-NONE-:[949..949] *T*))
            (VP (VBD:[950..958] received)
              (NP (NN:[960..983] pancreaticoduodenectomy))
              (PP (IN:[984..987] for)
                (NP
                  (NP
                    (NP (NN:[988..992] IPMN))
                    (PP (IN:[993..997] with)
                      (NP (DT:[998..999] a) (JJ:[1000..1005] focal)
                        (NML
                          (NML (FW:[1006..1008] in) (FW:[1009..1013] situ)
                               (NN:[1014..1023] carcinoma))
                          (NML (-LRB-:[1024..1025] -LRB-) (NN:[1025..1029] IPMC)
                               (-RRB-:[1029..1030] -RRB-))))))
                  (,:[1030..1031] ,)
                  (SBAR
                    (WHNP-1 (WDT:[1032..1037] which))
                    (S
                      (NP-SBJ-1 (-NONE-:[1037..1037] *T*))
                      (VP (VBD:[1039..1042] was)
                        (ADJP-PRD (JJ:[1043..1055] transitional)
                          (PP (TO:[1056..1058] to)
                            (NP
                              (NP (DT:[1059..1062] the)
                                  (VBG:[1063..1074] surrounding)
                                  (NN:[1075..1079] duct)
                                  (NN:[1080..1090] epithelium))
                              (PP (IN:[1091..1095] with)
                                (NP
                                  (NP (JJ:[1096..1105] papillary)
                                      (NN:[1106..1119] proliferation))
                                  (CC:[1121..1124] and)
                                  (NP
                                    (NP (DT:[1125..1126] a)
                                        (JJ:[1127..1131] wide)
                                        (NN:[1132..1139] variety))
                                    (PP (IN:[1140..1142] of)
                                      (NP (NN:[1143..1152] dysplasia)))))))))))))))))))
    (.:[1152..1153] .)))

;sentence 7 Span:1154..1337
;Nine years after the operation, she died of IDC  in the remnant pancreatic
;body and its surrounding duct epithelium consisted of  hyperplastic mucous
;cells with slight-mild dysplasia.
;[1198..1201]:malignancy:"IDC"
;[1284..1336]:malignancy:"hyperplastic mucous cells with slight-mild
;dysplasia"
(SENT
  (S
    (S
      (NP-TMP
        (NP (CD:[1154..1158] Nine) (NNS:[1159..1164] years))
        (PP-TMP (IN:[1165..1170] after)
          (NP (DT:[1171..1174] the) (NN:[1175..1184] operation))))
      (,:[1184..1185] ,)
      (NP-SBJ (PRP:[1186..1189] she))
      (VP (VBD:[1190..1194] died)
        (PP (IN:[1195..1197] of)
          (NP
            (NP (NN:[1198..1201] IDC))
            (PP-LOC (IN:[1203..1205] in)
              (NP (DT:[1206..1209] the) (NN:[1210..1217] remnant)
                  (JJ:[1218..1228] pancreatic) (NN:[1229..1233] body)))))))
    (CC:[1234..1237] and)
    (S
      (NP-SBJ (PRP$:[1238..1241] its) (VBG:[1242..1253] surrounding)
              (NN:[1254..1258] duct) (NN:[1259..1269] epithelium))
      (VP (VBD:[1270..1279] consisted)
        (PP-CLR (IN:[1280..1282] of)
          (NP
            (NP (JJ:[1284..1296] hyperplastic) (JJ:[1297..1303] mucous)
                (NNS:[1304..1309] cells))
            (PP (IN:[1310..1314] with)
              (NP
                (ADJP (JJ:[1315..1321] slight)
                  (PP (HYPH:[1321..1322] -)
                    (ADJP (JJ:[1322..1326] mild))))
                (NN:[1327..1336] dysplasia)))))))
    (.:[1336..1337] .)))

;sentence 8 Span:1338..1703
;Analysis of K-ras mutation  at codon 12 (wild-GGT) by direct sequencing after
;polymerase chain reaction  indicated that their transitioning patterns
;differed from each other: CGT in  IPMC; no mutation in the mildly dysplastic
;duct epithelium around IPMC; GAT in  IDC of the remnant pancreas; and AGT in
;mucous cell hyperplasia with mild  dysplasia close to the IDC.
;[1350..1355]:gene-rna:"K-ras"
;[1356..1364]:variation-event:"mutation"
;[1369..1377]:variation-location:"codon 12"
;[1379..1383]:variation-state-original:"wild"
;[1384..1387]:variation-state-altered:"GGT"
;[1416..1426]:gene-protein:"polymerase"
;[1513..1516]:variation-state-altered:"CGT"
;[1521..1525]:malignancy:"IPMC"
;[1530..1538]:variation-event:"mutation"
;[1546..1579]:malignancy:"mildly dysplastic duct epithelium"
;[1587..1591]:malignancy:"IPMC"
;[1593..1596]:variation-state-altered:"GAT"
;[1601..1628]:malignancy:"IDC of the remnant pancreas"
;[1634..1637]:variation-state-altered:"AGT"
;[1641..1685]:malignancy:"mucous cell hyperplasia with mild  dysplasia"
;[1699..1702]:malignancy:"IDC"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (NN:[1338..1346] Analysis))
        (PP (IN:[1347..1349] of)
          (NP
            (NP (NN:[1350..1355] K-ras) (NN:[1356..1364] mutation))
            (PP-LOC (IN:[1366..1368] at)
              (NP
                 (NN:[1369..1374] codon) (CD:[1375..1377] 12)
                (PRN (-LRB-:[1378..1379] -LRB-)
                  (NP (JJ:[1379..1383] wild) (HYPH:[1383..1384] -)
                      (NN:[1384..1387] GGT))
                  (-RRB-:[1387..1388] -RRB-)))))))
      (PP (IN:[1389..1391] by)
        (NP
          (NP (JJ:[1392..1398] direct) (NN:[1399..1409] sequencing))
          (PP-TMP (IN:[1410..1415] after)
            (NP (NN:[1416..1426] polymerase) (NN:[1427..1432] chain)
                (NN:[1433..1441] reaction))))))
    (VP (VBD:[1443..1452] indicated)
      (SBAR (IN:[1453..1457] that)
        (S
          (NP-SBJ
            (NP (PRP$:[1458..1463] their) (VBG:[1464..1477] transitioning)
                (NNS:[1478..1486] patterns))
            (NP-1 (-NONE-:[1486..1486] *ICH*)))
          (VP (VBD:[1487..1495] differed)
            (PP (IN:[1496..1500] from)
              (NP (DT:[1501..1505] each) (JJ:[1506..1511] other)))
            (::[1511..1512] :)
            (NP-1
              (NP
                (NP (NN:[1513..1516] CGT))
                (PP (IN:[1517..1519] in)
                  (NP (NN:[1521..1525] IPMC))))
              (::[1525..1526] ;)
              (NP
                (NP (DT:[1527..1529] no) (NN:[1530..1538] mutation))
                (PP (IN:[1539..1541] in)
                  (NP
                    (NP (DT:[1542..1545] the)
                      
                      (ADJP (RB:[1546..1552] mildly)
                            (JJ:[1553..1563] dysplastic))
                      (NN:[1564..1568] duct) (NN:[1569..1579] epithelium))
                    (PP (IN:[1580..1586] around)
                      (NP (NN:[1587..1591] IPMC))))))
              (::[1591..1592] ;)
              (NP
                (NP (NN:[1593..1596] GAT))
                (PP (IN:[1597..1599] in)
                  (NP
                    (NP (NN:[1601..1604] IDC))
                    (PP (IN:[1605..1607] of)
                      (NP (DT:[1608..1611] the) (NN:[1612..1619] remnant)
                          (NN:[1620..1628] pancreas))))))
              (::[1628..1629] ;) (CC:[1630..1633] and)
              (NP
                (NP (NN:[1634..1637] AGT))
                (PP (IN:[1638..1640] in)
                  (NP
                    (NP (JJ:[1641..1647] mucous) (NN:[1648..1652] cell)
                        (NN:[1653..1664] hyperplasia))
                    (PP (IN:[1665..1669] with)
                      (NP
                        (NP (JJ:[1670..1674] mild) (NN:[1676..1685] dysplasia))
                        (ADJP-LOC (JJ:[1686..1691] close)
                          (PP (TO:[1692..1694] to)
                            (NP (DT:[1695..1698] the) (NN:[1699..1702] IDC))))))))))))))
    (.:[1702..1703] .)))

;sentence 9 Span:1704..1859
;This is the first report in which the DNA sequence  of K-ras mutation was
;determined for the two sporadic pancreatic cancers and  surrounding duct
;changes.
;[1759..1764]:gene-rna:"K-ras"
;[1765..1773]:variation-event:"mutation"
;[1801..1828]:malignancy:"sporadic pancreatic cancers"
(SENT
  (S
    (NP-SBJ (DT:[1704..1708] This))
    (VP (VBZ:[1709..1711] is)
      (NP-PRD
        (NP (DT:[1712..1715] the) (JJ:[1716..1721] first)
            (NN:[1722..1728] report))
        (SBAR
          (WHPP-2 (IN:[1729..1731] in)
            (WHNP (WDT:[1732..1737] which)))
          (S
            (NP-SBJ-1
              (NP (DT:[1738..1741] the) (NN:[1742..1745] DNA)
                  (NN:[1746..1754] sequence))
              (PP (IN:[1756..1758] of)
                (NP (NN:[1759..1764] K-ras) (NN:[1765..1773] mutation))))
            (VP (VBD:[1774..1777] was)
              (VP (VBN:[1778..1788] determined)
                (NP-1 (-NONE-:[1788..1788] *))
                (PP (IN:[1789..1792] for)
                  (NP
                    (NP (DT:[1793..1796] the) (CD:[1797..1800] two)
                       (JJ:[1801..1809] sporadic) (JJ:[1810..1820] pancreatic)
                       (NNS:[1821..1828] cancers))
                    (CC:[1829..1832] and)
                    (NP (VBG:[1834..1845] surrounding) (NN:[1846..1850] duct)
                        (NNS:[1851..1858] changes))))
                (PP-2 (-NONE-:[1858..1858] *T*))))))))
    (.:[1858..1859] .)))

;sentence 10 Span:1860..2090
;The following two suggestions are made: (1) the  cell-origin might have
;differed between the two types of cancer (IDC and IPMC);  and (2) no
;precursor lesion toward IDC or IPMC was identified in their  surrounding duct
;epithelium.
;[1966..1972]:malignancy:"cancer"
;[1974..1977]:malignancy:"IDC"
;[1982..1986]:malignancy:"IPMC"
;[2025..2028]:malignancy:"IDC"
;[2032..2036]:malignancy:"IPMC"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1860..1863] The) (VBG:[1864..1873] following)
          (CD:[1874..1877] two) (NNS:[1878..1889] suggestions))
      (S-3 (-NONE-:[1889..1889] *ICH*)))
    (VP (VBP:[1890..1893] are)
      (VP (VBN:[1894..1898] made)
        (NP-2 (-NONE-:[1898..1898] *))
        (::[1898..1899] :)
        (S-3
          (LST (LS:[1900..1903] -LRB-1-RRB-))
          (S
            (NP-SBJ (DT:[1904..1907] the) (NN:[1909..1913] cell)
                    (HYPH:[1913..1914] -) (NN:[1914..1920] origin))
            (VP (MD:[1921..1926] might)
              (VP (VB:[1927..1931] have)
                (VP (VBN:[1932..1940] differed)
                  (PP (IN:[1941..1948] between)
                    (NP
                      (NP (DT:[1949..1952] the) (CD:[1953..1956] two)
                          (NNS:[1957..1962] types))
                      (PP (IN:[1963..1965] of)
                        (NP (NN:[1966..1972] cancer)))
                      (PRN (-LRB-:[1973..1974] -LRB-)
                        (NP (NN:[1974..1977] IDC) (CC:[1978..1981] and)
                            (NN:[1982..1986] IPMC))
                        (-RRB-:[1986..1987] -RRB-))))))))
          (::[1987..1988] ;) (CC:[1990..1993] and)
          (LST (LS:[1994..1997] -LRB-2-RRB-))
          (S
            (NP-SBJ-1
              (NP (DT:[1998..2000] no) (NN:[2001..2010] precursor)
                  (NN:[2011..2017] lesion))
              (PP (IN:[2018..2024] toward)
                (NP (NN:[2025..2028] IDC) (CC:[2029..2031] or)
                    (NN:[2032..2036] IPMC))))
            (VP (VBD:[2037..2040] was)
              (VP (VBN:[2041..2051] identified)
                (NP-1 (-NONE-:[2051..2051] *))
                (PP (IN:[2052..2054] in)
                  (NP (PRP$:[2055..2060] their) (VBG:[2062..2073] surrounding)
                      (NN:[2074..2078] duct) (NN:[2079..2089] epithelium)))))))))
    (.:[2089..2090] .)))

;section 11 Span:2094..2139
;PMID: 12072425 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2094..2098] PMID) (::[2098..2099] :) (CD:[2100..2108] 12072425)
        (NN:[2109..2110] -LSB-) (NNP:[2110..2116] PubMed) (::[2117..2118] -)
        (NN:[2119..2126] indexed) (IN:[2127..2130] for)
        (NNP:[2131..2139] MEDLINE-RSB-)))
